Literature DB >> 339214

A comparison of once and twice daily atenolol in hypertension.

C M Castleden, J R Dathan, C F George.   

Abstract

The hypertensive action of atenolol has been studied in a randomized double-blind crossover comparison. Twelve patients showed a highly significant reduction in average supine systolic and diastolic blood pressures from pre-treatment values of 196.3/115.9 to 159.1/89.2 mmHg (26.1/15.4 kPa to 22.2/11.9 kPa) after 2 weeks on once daily atenolol. No dose-related reduction in blood pressure was seen and the single 100 mg daily dose was as effective as 100 mg twice daily or 50 mg twice daily. Blood pressures recorded after 2 weeks' atenolol were lower than those obtained at 7 days irrespective of dose.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 339214      PMCID: PMC2496839          DOI: 10.1136/pgmj.53.625.679

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  5 in total

1.  The relationship between beta-blockade, hyporeninaemic and hypotensive effect of two beta-blocking agents.

Authors:  A Amery; J F De Plaen; R Fagard; P Linjen; T Reybrouck
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

2.  Raynaud's phenomenon as side effect of beta-blockers in hypertension.

Authors:  A J Marshall; C J Roberts; D W Barritt
Journal:  Br Med J       Date:  1976-06-19

3.  Once-daily dosing with Atenolol in patients with mild or moderate hypertension.

Authors:  A P Douglas-Jones; J M Cruickshank
Journal:  Br Med J       Date:  1976-04-24

4.  Atenolol in essential hypertension.

Authors:  M G Myers; G R Lewis; J Steiner; C T Dollery
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

5.  Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.

Authors:  F J Conway; J D Fitzgerald; J McAinsh; D J Rowlands; W T Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

  5 in total
  5 in total

1.  Randomised study of six beta-blockers and a thiazide diuretic in essential hypertension.

Authors:  R G Wilcox
Journal:  Br Med J       Date:  1978-08-05

2.  Comparison of ocular hypotensive effects of 3 dosages of oral atenolol.

Authors:  M K Tutton; R J Smith
Journal:  Br J Ophthalmol       Date:  1983-10       Impact factor: 4.638

3.  Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.

Authors:  G Leonetti; L Terzoli; C Bianchini; C Sala; A Zanchetti
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

Review 4.  Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

5.  Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.

Authors:  J S Floras; J V Jones; M O Hassan; P Sleight
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.